Search results for "Cut"

showing 10 items of 5063 documents

The Impact of School Closure on Adolescents’ Wellbeing, and Steps toward to a New Normal : The Need for an Assessment Tool Update?

2021

International audience; Close to 200 countries have implemented school closures to decrease the spread of the COVID-19 coronavirus. Though the closures have seemed necessary, their effects on the wellbeing of children and adolescents have raised serious concerns. To truly understand the impact of such disruption on young people’s wellbeing, and their views on how to move towards a new normal, we must adopt different approaches to gather the data to secure children’s and adolescents’ rights to be heard in the issues that concern their lives. Current ways to examine the impacts of school closure have been dominated by gathering information concerning the children and adolescents, using mainly…

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[SHS.EDU]Humanities and Social Sciences/EducationassessmenthyvinvointiRC435-571PediatricsRJ1-570Developmental psychologywellbeingnuoretetäopetusmedicinePsychologyadolescentsPsychiatrykoulutsulkeminenPublic healthCOVID-19General Medicineschool closureBF1-990New normalpoikkeusolot[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePsychology
researchProduct

Therapeutic advances from the 16th Baltic Association of Dermatovenereologists Congress, University of Latvia, Riga, Latvia Hybrid Conference: Zoom t…

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryFamily medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicineDermatologyGeneral MedicinebusinessDermatologic Therapy
researchProduct

¿ Será mejor la salud pública tras la COVID-19?

2021

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryPublic healthFamily medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:Public aspects of medicinePublic Health Environmental and Occupational HealthMEDLINEMedicinelcsh:RA1-1270businessGaceta Sanitaria
researchProduct

Reducing mortality from 2019-nCoV: host-directed therapies should be an option

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralImmunization PassiveCOVID-19General MedicineGlobal HealthArticleCOVID-19 Drug TreatmentBetacoronavirusDrug DiscoveryViral therapyMedicineHumansbusinessIntensive care medicineCoronavirus InfectionsHost (network)PandemicsCOVID-19 SerotherapyThe Lancet
researchProduct

An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19Angiotensin-Converting Enzyme InhibitorsPharmacologyPolymorphism Single NucleotideAngiotensin Receptor AntagonistsEpidemiologic StudiesRisk FactorsEpidemiologyPlasma concentrationmedicineHumansAngiotensin-Converting Enzyme 2Angiotensin Receptor BlockersCardiology and Cardiovascular MedicinebusinessMolecular BiologyJournal of Molecular and Cellular Cardiology
researchProduct

Out-of-hospital cardiac arrest during the COVID-19 era: The importance to fight against fear

2021

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19General MedicineFearBystanderOut of hospital cardiac arrestArticleEmergency medicineEmergency MedicinemedicineOHCACPRbusinessThe American Journal of Emergency Medicine
researchProduct

Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management

2020

Currently, there is no effective therapy for COVID-19, and several approaches are under investigation. Nevertheless, some drugs are used off-label despite the absence of clear data on their effectiveness. Among these, hydroxychloroquine suppresses SARS-CoV-2 replication in vitro,1 and clinical trials are ongoing to evaluate its use as an anti-COVID-19 agent. To date, the FDA and EMA allow its use only in hospitalized patients with severe COVID-19 or in those at high risk, in cases where other trials are not feasible. According to a small non-randomized study, hydroxychloroquine’s efficacy might be enhanced by azithromycin, as the combination of these two drugs appeared to accelerate viral c…

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19MinocyclineMinocyclineAzithromycinAzithromycinAnti-Bacterial AgentsCOVID-19 Drug TreatmentSettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARECorrespondenceHumansMedicinePharmacology (medical)Cardiology and Cardiovascular MedicinebusinessIntensive care medicineCOVID 19medicine.drugEuropean Heart Journal - Cardiovascular Pharmacotherapy
researchProduct

Differential impact of COVID-related lockdown on mental health in Germany.

2021

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEMental healthPsychiatry and Mental healthmedicinePhychiatric Mental HealthPshychiatric Mental HealthPsychiatrybusinessLetters to the EditorDifferential impactWorld psychiatry : official journal of the World Psychiatric Association (WPA)
researchProduct

The war against coronavirus disease 19 through the eyes of cancer physician: An Italian and Indian young medical oncologist's perspective

2020

These are unprecedented times, we are living in with an outbreak of a novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (CoV-2), or CoV Disease 19 (COVID-19). By April 20th, as per the World Health Organization Data, COVID-19 as a pandemic has caused 2,407,414 cases, and 165,073 confirmed deaths in 213 different countries worldwide. Elderly patients and those with comorbid illnesses with COVID-19 infection have poor outcomes. Cancer patients are immunosuppressed, and at an increased risk of COVID-19 infection and have worse outcomes as compared to the general population. The mortality rate of COVID-19 among oncology patients is about 20%.[1] Young oncologists …

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Perspective (graphical)CancerDiseasemedicine.disease_causemedicine.diseaseSpanish Civil Waroncology covid-19OncologyFamily medicinePediatrics Perinatology and Child HealthmedicinebusinessCoronavirus
researchProduct

Letter of Reply to “Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinant…

2021

To the Editors, We thank Drs. R. Mungmunpuntipantip and V. Wiwanitkit1 for their comment on our recently published article, “COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association”.

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)WillingneGastroenterologyMEDLINEHesitancyInflammatory Bowel DiseasesInflammatory Bowel DiseasesVaccinationInternal medicineImmunology and AllergyMedicineIn patientbusinessInflammatory Bowel Diseases
researchProduct